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Abstract.  Initial assembly of extracellular matrix oc- 
curs within a zone immediately adjacent to the chon- 
drocyte cell surface termed the cell-associated or 
periceUular matrix.  Assembly within the periceUular 
matrix compartment requires specific cell-matrix in- 
teractions to occur, that are mediated via membrane 
receptors.  The focus of this study is to elucidate the 
mechanisms of assembly and retention of the cartilage 
pericellular matrix proteoglycan aggregates important 
for matrix organization.  Assembly of newly synthe- 
sized chondrocyte pericellular matrices was inhibited 
by the addition to hyaluronan hexasaccharides,  com- 
petitive inhibitors of the binding of hyaluronan to its 
cell surface receptor.  Fully assembled chondrocyte 
pericellular matrices were displaced using hyaluronan 
hexasaccharides as well. 
When exogenous hyaluronan was added to matrix- 
free chondrocytes in combination with aggrecan,  a 
pericellular matrix equivalent in size to an endogenous 
matrix  formed within 30 min of incubation.  Addition 
of hyaluronan and aggrecan to glutaraldehyde-fixed 
chondrocytes resulted in matrix assembly comparable 
to live chondrocytes.  These matrices could be in- 
hibited from assembling by the addition of excess 
hyaluronan hexasaccharides or displaced once assem- 
bled by subsequent incubation with hyaluronan hexa- 
saccharides.  The results indicate that the aggrecan- 
rich chondrocyte pericellular matrix is not only on a 
scaffolding of hyaluronan,  but actually anchored to 
the cell surface via the interaction between hyaluronan 
and hyaluronan receptors. 
T 
am initial  assembly of the chondrocyte extracellular 
matrix most likely occurs near the cell surface within 
a  zone  termed  the  cell-associated  or  pericellular 
matrix.  How this assembly is regulated by the chondrocytes 
and how the matrix itself is anchored to the cell surface is 
largely  unknown.  Hyaluronan,  a  high  molecular  weight 
matrix polysaccharide, has a central role in the organization 
of the extracellular matrix of cartilage as the backbone of the 
cartilage proteoglycan aggregate (Hascall and Heinegard, 
1974; Christner et al.,  1977). In the pericellular matrix of 
chondrocytes where it is an essential  matrix  component, 
hyaiuronan may not only serve a structural  role, but other 
functions  as well. 
Chondrocytes in culture exhibit large pericellular matrices 
extending  from the plasma membrane which can be readily 
visualized by a particle exclusion assay (Clarris  and Fraser, 
1968;  Goldberg  and  Toole,  1984;  Knudson  and  Toole, 
1985).  Small particles  when added to low density cultures 
settle onto the culture dish, and are excluded from a distinct 
zone  surrounding  the  chondrocytes.  This  zone  or  "coat" 
defines the chondrocyte pericellular matrix. A major compo- 
nent of this matrix is the large,  chondroitin  sulfate-rich  ag- 
gregating  proteoglycan,  termed '~ggrecan"  (Doege et al., 
1991). Treatment  of chondrocytes with a small  amount of 
Streptomyces hyaluronidase,  which  specifically  degrades 
hyaluronan (Ohya and Kaneko, 1970; Harrison et al., 1986), 
removes this pericellular matrix (Goldberg and Toole, 1984; 
Knudson and Toole, 1985; McCarthy and Toole, 1989) sug- 
gesting that the majority of the aggrecan is in the form of ag- 
gregates  with hyaluronan.  The  focus of this  study is the 
mechanism  of retention  of these proteoglycan aggregates in 
order to elucidate the interactions  important to establish and 
maintain  chondrocyte pericellular matrix organization. 
Many cells, including chondrocytes (Knudson and Toole, 
1987; McCarthy and Toole, 1989; Toole et al.,  1989; Yu et 
al.,  1992),  have  specific  cell surface binding  proteins,  or 
receptors, for hyaluronan.  Hyaluronan  receptors present on 
chondrocytes have properties similar  to hyaluronan  recep- 
tors reported on other cell types such as SV-40 transformed 
3T3, BHK, and human bladder carcinoma cells (Underhill 
and Toole,  1979;  Underhill,  1989;  Nemec et ai.,  1987). 
These hyaluronan receptors are a family of non-integrin,  hy- 
drophobic  membrane  proteins,  termed  the  hyaladherins 
(Toole,  1991). Studies have also suggested that hyaluronan 
receptors are related or identical to the CD44 family of lym- 
phocyte homing receptors (Aruffo et al., 1990; Culty et al., 
1990). The hyaiuronan  receptors are grouped together as a 
family based on their similar physical and functional proper- 
ties which include:  (a) a high binding affinity for hyaluronan 
(Kd ------- 10  -9 M); (b) a high degree of specificity for hyaluro- 
nan (when receptor is assayed on non-extracted,  intact mem- 
branes);  (c) binding  affinity  for hyaluronan  that  increases 
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mild fixation of the receptor with glutaraldehyde; and lastly 
(e) binding that can be competed by hyaluronan oligosaccha- 
rides with a minimum size of six monosaccharides.  These 
and  other  properties  help  to  distinguish  this  family  of 
hyaluronan binding proteins/receptors from other hyaluro- 
nan binding proteins  including aggrecan and link protein. 
One important property shared by all the CD44-1ike cell 
surface hyaluronan receptors is the minimum size of  hyaluro- 
nan oligosaccharide required to effectively compete for the 
binding  of native  hyaluronan  to  its  receptor,  which is  a 
hyaluronan hexasaccharide (HA0 ~. This property is helpful 
in differentiating the specific binding of hyaluronan to the 
receptor from the aggregation of hyaluronan with other ma- 
trix macromolecules, in particular aggrecan and link pro- 
tein, which require a minimum sequence of 10-12 monosac- 
charides for competition (Hascall  and Heinegard,  1974; 
Christner et al., 1977; Hardingham et al., 1992). Incubation 
of cells  with HA~ has been shown to displace  pre-bound 
3H-hyaluronan from cell surfaces (Nemec et al.,  1987), to 
compete with binding when added together with 3H-hyal- 
uronan to intact ceils (Underhill and Toole, 1979) or isolated 
cell membranes (Underhill et al,,  1983), and in this study 
to inhibit assembly of newly synthesized chondrocyte peri- 
cellular matrices.  A large proportion of endogenous hyalu- 
ronan can be displaced from the cell surface by exogenous 
hyaluronan or HA~; proteoglycans are also displaced along 
with the hyaluronan (Knudson and Toole, 1987; Knudson, 
C. B,, L. J. Coombs, and K. E. Kuettner, 1991. Ortho Trans. 
15:467-468;  Hua,  Q.,  C.  B.  Knudson,  and W.  Knudson, 
1992. Trans. Orthop. Res. Soc. 17:29). As shown in this pa- 
per, HA~ can displace fully assembled chondrocyte  pericel- 
lular matrices. 
This study characterizes the roles of hyaluronan,  aggre- 
can, and cell surface hyaluronan receptors in the assembly, 
organization, and maintenance of the chondrocyte  pericellu- 
lar matrix. Two cell types are used as model systems for 
study; embryonic chick tibial chondrocytes (Kim and Con- 
rad,  1977; Knudson and Toole, 1985, 1987) and adult rat 
chondrocytes,  derived from the well-characterized Swarm 
rat chondrosarcoma (Kimura et al., 1979; Sun et al., 1986). 
The  results  indicate  that  the  aggrecan-rich chondrocyte 
pericellular matrix is anchored to the cell surface via the in- 
teraction between hyaluronan  and  hyaluronan  receptors, 
Therefore, the hyaluronan receptors may direct the assembly 
of the chondrocyte pericellular matrix. 
Materials and Methods 
All  reagents,  unless  specified  otherwise,  were  purchased  from  Sigma 
Chemical Co.  (St. Louis, MO). Tissue culture samples were from Gibco 
BRL (Grand Island, NY). 
Chondrocytes and Culture Conditions 
Embryonic chick chondrocytes  were released from stage 38 tibiae (Ham- 
burger and Hamilton, 1951), zone II cartilage segments (Kim and Conrad, 
1977), by trypsin (type II)/collagenase  (type II; Wbrthington, Freehold, NJ) 
treatment (Knudson and Toole,  1985).  Rat chondrosareoma chondrocytes 
from long-term continuous cell cultures were obtained from Dr. James H. 
1. Abbreviations used in this paper: CMF-PBS, Calcium- and magnesium- 
free PBS; HAs, hyaluronan hexasaecharides; polyhema, poly-2-hydroxy- 
ethylmethacrylate. 
Kimura (Henry Ford Hospital, Detroit, MI). The two chondrocyte types 
were cultured in DME (4.5 g/l glucose) containing 10% FBS (Hyclone, Lo- 
gan, UT), 1% penicillin/streptomycin  solution, 50 #g/ml ascorbic acid and 
2 mM glntamine, at 37~  in 5% CO2/95%  air.  Chondrocytes were also 
grown in suspension cultures over poly-2-hydroxyethylmcthacrylate  coating 
(polyhema; Aldrich, Milwaukee, WI) in complete medium. To coat the sur- 
face, 35-mm tissue culture dishes containing 2 ml of 0.06% polyhcma in 
ethanol were incubated to dryness at 37~ 
Particle Exclusion Assay 
The particle exclusion assay followed a protocol described previously  for 
cells in monolayer culture (Knudson and Toole, 1985). The culture medium 
was removed and replaced with 750 #l of a suspension of formaldehyde- 
fixed RBCs (108/ml) in PBS/0.1% BSA. The particles settled in 10 rain, 
and the cells were then observed by phase-contrast microscopy. To visualize 
the pericellular matrix assembled by chondrocytes  in suspension culture, 
cells were transferred to 6-well flat-bottom tissue culture plates and spun 
at 500 g for 15 rain in an Omnifuge microtiter plate holder before the addi- 
tion of particles. 
Morphometric Analysis of  Matrix to Cell Area 
A matrix/cell ratio, defined as the ratio of the area delimited by the perime- 
ter of  the pericellular matrix to the area delimited by the plasma membrane, 
was determined by tracing the matrix and cell perimeters on a digitizing tab- 
let using Sigma  Scan  software  (Jandel  Scientific,  Corte  Madera, CA; Knud- 
son and Toole, 1985). The matrix/cell  ratio  was ,x,l.0  if no detectable 
periccllular  matrix was present.  The values  given represent  the mean ma- 
trix/cell  ratio  and the  95  % confidence range from the  mean. Experimental 
groups were compared with regard to control  by a t  test. 
Enzymatic Removal of  PericeUular Matrix 
For studies on assembly of newly synthesized pericellular matrix, the en- 
dogenous pericellular matrices were removed by adding 20 ~1 of a 100 U/ml 
solution of Streptomyces hyaluronidase (type IX) directly to 24-h chondro- 
cyte cultures,  containing complete culture medium with 10% FBS, and in- 
cubating the cells for 1 h at 37~  followed by HBSS washes.  After this 
treatment, the ceils were "matrix-free" by the particle exclusion assay. Fol- 
lowing Streptomyces hyaluronidase treatment, some cells were fixed in 1% 
glutaraldehyde  (EMS,  Fort Washington,  PA) in PBS,  for 5 rain, and then 
rinsed with PBS/I%  BSA. 
Matrix Assembly and Displacement Studies 
The influence of HA6 or high molecular weight hyaluronan  on matrix as- 
sembly was studied.  HAs can compete for the binding of hyaluronan to its 
receptor but cannot support proteoglycan  aggregate  formation. Chondro- 
cytes were made matrix-free with Streptomyces hyaluronidase.  1Ceassembly 
of the endogenous pericellular matrix was monitored in complete medium 
or medium containing hyaluronan (250/~g/mi), or HA6 (25-125 #g/ml). 
The ability of exogenous  hyaluronan  and HAS to displace the endoge- 
nous matrix made by chondrocytes in suspension culture over polyhema, 
or chondrocytes grown as attached ceils in monolayer, was also determined. 
Cells grown under these culture conditions for 2 to 48 h were incubated for 
2 to 3 h more in the presence or absence of hyaluronan or HA6 before the 
particle exclusion assay. 
Preparation and Addition of 
Exogenous Macromolecules 
To test the ability of chondrocytes to assemble a pericellular matrix with 
exogenous  macromolecules,  hyaluronan  and  aggrecan  were  added  to 
matrix-free  live or glutaraldchydc-fixed  cells.  Initially,  aggrecan derived 
from several sources was tested; monomer preparations from the Swarm rat 
chondrosarcoma were gifts from Drs. J. Kimura and 1". Giant (Henry Ford 
Hospital, Detroit, MI and Rush-Presby~rian-St. Luke's Medical Center, 
Chicago, IL, respectively),  and, proteoglycan monomers derived from adult 
bovine articular or nasal cartilages were gifts from Dr. E. Thonar (Rush- 
Presbyterian-St.  Luke's Medical Center). Subsequently,  proteoglycan  was 
extracted  from rat chondrosarcoma tumor homogenate according to Faltz 
et al. (1979) and isolated by dissociative cesium chloride equilibrium cen- 
trifugation in 4.0 M guauldine HC1 with protease inhibitors at a starting 
density of 1.5 g/ml (Hascall vtal.,  1976) for 50 h at 100,000 g at 10~ 
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centrifuged. The bottom 1/4th of the second gradient was collected (DID1 
fractions), dialyzed, and lyophilized. The D1DI  fractions were incubated 
with  Streptomyces  hyaluronidase  to  degrade  small  concentrations  of 
hyaluronan found within these preparations. The proteoglycans were recov- 
ered by another dissociative equilibrium centrifugation. 
HA6 were prepared by digestion of hyaluronan (grade I) with testicular 
hyaluronidase (type I-S) with 172 USP/NFU hyaluronidase/mg hyaluronan 
(Knudson et al.,  1984; Kimura et al., 1979; Hascall and Heinegard, 1974). 
The hyaluronan oligosaccharides were separated on a 2.5 x  118 cm column 
of Bit-gel P30 in 0.5 M pyridinium acetate (Solursh et al.,  1980; Knudson 
and Knudson,  1991). 
In parallel experiments, the glycosaminoglycan chondroitin sulfate was 
added to chondrocytes cultures.  Chondroitin sulfate (grade III) was pre- 
treated  with  Streptomyces hyaluronidase,  boiled,  precipitated  in  1.3% 
potassium  acetate  in 95%  ethanol.  Chondroitin sulfate hexasaccharides 
were prepared  by testicular hyaluronidase digestion,  purified by Bit-gel 
P-30 chromatography as above. 
Additions to matrix-free chondrocytes were DME containing either: (a) 
no additional components; (b) 2.0 mg/ml proteoglycan monomer;  (c)  12 
~g/ml hyaluronan;  (d) 2.0 mg/ml proteoglycan monomer plus  12  /~g/ml 
hyaluronan (determined empirically as optimal, data not shown); or (e) 2.0 
mg/ml proteoglycan monomer,  12 t~g/ml hyaluronan, and 100/~g/ml HA6. 
The hyaluronic acid binding region of D1D1 proteoglycan was separated 
from the chondroitin sulfate-rich fragment by dissociative cesium chloride 
gradient centrifugation as above, after clostripain digestion (Caputo et al., 
1980). Reduction/alkylation of proteoglycan was by treatment with 20 mM 
DTT followed by addition of iodoacetamide (Hardingham et al., 1976). The 
products of chondroitinase ABC digestion (Hascall and Heinegard,  1974), 
were separated by Sephacryl S-300 chromatography in PBS. The proteogly- 
can core protein, containing chondroitin-4-sulfate stubs, was detected using 
9-A-2/E9 antibody (ICN  Biomedicals,  Inc., Irvine, CA).  Residual chon- 
droitinase activity was detected in later eluting fractions by 3H-hyaluronan 
degradation assays (Knudson and Toole, 1987). Modified proteoglycan was 
lyophilized, dissolved in DME at 10 ng/ml, and added to matrix-free chon- 
drocytes at the same concentration as the native proteoglycan. 
The ability of aggrecan to associate with chondrocytes in monolayer cul- 
ture was tested by adding 3H-aggrecan to matrix-free chondrocytes or to 
chondrocytes  with an endogenous pericellular matrix.  The 3H-aggrecan 
(Byers et al.,  1987) was added at 1 mg/ml (62,000 cpm/mg) serum-free 
DME per 105 cells for 2 h at 37~  Cells were then rinsed three times with 
serum-free DME;  the radioactivity was released from the culture dishes 
with  1% SDS. 
Proteoglycan Biosynthesis in the Presence of 
Hyaluronan Hexasaccharides 
Matrix-free chondrocytes were incubated with 25 #Ci/ml of [35S]sulfuric 
acid (43 Ci/mg; ICN Biomedicals) in the presence or absence of 250 t~g/ml 
HA6. The media fractions were collected at 24 and 48 h and analyzed by 
descending chromatography (Knudson et al.,  1984). Chondroitinase ABC- 
sensitive radioactivity at the origin of the strip represented incorporation 
into  chondroitin  sulfate  proteoglycan.  Samples  were  also  run  on  a 
Sepharose CL-2B column in 0.5 M sodium acetate, 0.1% Triton X-100, pH 
6.8, with and without pre-aggregation with hyaluronan for 24 h  (Sandy et 
al.,  1989).  The percentage of macromolecular [35S]sulfate-labeled mate- 
rial eluting at the Vo of the column represents the capacity of the radiola- 
beled proteoglycan to form stable aggregates with hyaluronan. 
Results 
Inhibition of  Matrix Assembly 
Our model system for matrix assembly uses chondrocytes in 
monolayer (Fig. 1, a and b) or suspension culture. The ma- 
trix of these chondrocytes was removed with Streptomyces 
hyaluronidase, and then reassembly of newly synthesized 
pericellular matrices was followed from 2 h up to 5 d. This 
matrix assembly was monitored in the presence of HA6 to 
test the hypothesis that receptor-bound hyaluronan, that ex- 
hibits competition via a hexasaccharide, functions to anchor 
the chondrocyte pericellular matrix. Chondrocytes stripped 
of their pericellular matrix with hyaluronidase reassembled 
a small pericellular matrix by 3 h and a typical matrix (Fig. 
1, c and d) by 24 h. Fig. 1, e and  f, shows that matrix assem- 
bly on both chick embryo chondrocytes and rat chondrocytes 
was  inhibited by the presence of 0.25  mg/ml HA6 in the 
medium. In the extended presence of 0.25  mg/ml HAs, no 
matrix was detected after 5 d of culture (data not shown). In 
these studies, the HA6 were added at time zero, and there 
were no further additions to the cultures. 
Chondrocytes that had no matrix after a 24-h incubation 
in the presence of HA6 (as in Fig.  1, e and f), were rinsed 
twice in HBSS  and then incubated in  fresh medium.  As 
shown in Table I, after 4 h a small pericellular matrix was 
observed on these chondrocytes and by 24 h following the 
wash out of HA6, pericellular matrix assembly was similar 
in size to chondrocytes in culture for 24 h. 
There was a dose-dependent inhibition of matrix assembly 
by HA~ as shown in Table  II. Addition of hyaluronan did 
not inhibit matrix assembly. The time course for matrix as- 
sembly  on  chondrocytes  in  monolayer culture  following 
Streptomyces hyaiuronidase treatment in the presence or ab- 
sence of exogenous hyaluronan was nearly identical (Table 
III). In the presence of chondroitin sulfate or its hexasaccha- 
rides pericellular matrix assembly was similar to controls for 
chick chondrocytes, although rat chondrocyte matrix size 
was decreased somewhat (P <  0.02).  The concentration of 
chondroitin sulfate in these cultures has a viscosity nearly 
equal  to  that  of the  hyaluronan  solution  (Forrester  and 
Lackie, 1981). 
Displacement of  FuUy Assembled Pericellular Matrix 
When chondrocytes in monolayer culture for 20 h (Fig. 2, 
a  and c) were subsequently incubated for an additional 2 h 
in medium containing HA6, the entire pericellular matrix 
was displaced (Fig. 2, b and d; see also Table IV). Although 
we had shown previously that hyaluronan could displace ra- 
diolabeled  hyaluronan  and  chondroitin  sulfate  from  the 
chondrocyte cell surface (Knudson and Toole,  1987),  addi- 
tion of hyaluronan did not displace the fully assembled en- 
dogenous pericellular matrix (Table IV). Also the addition 
of chondroitin sulfate, chondroitin sulfate hexasaccharides, 
or proteoglycan monomer did not displace the fully assem- 
bled endogenous pericellular matrix (Table IV). Exogenous 
aggrecan monomer may also be incorporated into a hyal- 
uronan-anchored periceUular matrix since the matrix size 
was increased in the presence of aggrecan (P < 0.001). Chon- 
droitin sulfate hexasaccharides did not displace the matrix, 
indicative of the specificity of the hyaluronan receptor. 
Matrix Assembly and Displacement on Chondrocytes 
Grown in Suspension Culture 
Chondrocytes were grown in  suspension over polyhema- 
coated plastic for 48 h, then centrifuged at 500 g for 15 min 
onto plastic for immediate analysis by the particle exclusion 
assay. 90% of the cells adhered were viable by trypan blue 
exclusion, and exhibited a periceUular matrix (Fig. 3, a and 
c). If ceils from 48 h suspension cultures were incubated for 
an additional 3 h in the presence of HA6 and then visual- 
ized, the endogenous matrix was displaced (Fig. 3, b and d). 
Knudson Hyaluronan Receptor in Chondrocyte Matrix Assembly  827 Figure 1.  Chondrocyte  peri- 
cellular matrix assembly; in- 
hibition  by hyaluronan hexasac- 
charides. Chondrocytes grown 
in monolayer  were well-spread 
24  h  following  plating  (a 
and  b).  These  chondrocytes, 
stripped of matrix with hyal- 
uronidase, reassembled a peri- 
cellular  matrix  in  complete 
medium after 24 h as observed 
with  the  particle  exclusion 
method (c and d). However, if 
chondroeytes were stripped of 
matrix and then incubated with 
0.25  mg/ml  HA~  no  matrix 
was observed after 24 h (e and 
f).  a,  c,  and e  show embry- 
onic chick chondrocytes; b, d, 
and f  show rat chondrocytes. 
Bar, 50/zm. 
Matrix Assembly with Exogenous Hyaluronan 
and Aggrecan 
To determine which molecules are required for pericellular 
matrix  assembly,  exogenous  aggrecan,  hyaluronan,  and 
HA~  were  added  in  combinations  to  matrix-free  rat  and 
chick chondrocytes. No matrix assembled for up to 2 h when 
hyaluronan alone (Fig. 4,  c  and d) was added.  Addition of 
3H-hyaluronan to these cells resulted in specific, saturable 
binding  (chick chondrocytes Kd ~  6  X  10  -9 M;  Knudson 
and Toole, 1987; rat chondrocytes Ko =  10  -1~ M; McCarthy 
and Toole, 1989), but hyaluronan alone was not sufficient for 
matrix assembly. No matrix assembled for up to 2  h  when 
aggrecan alone (Fig. 4, e and f) was added. A large pericel- 
lular matrix assembled within 30 man when both hyaluronan 
and aggrecan were added to matrix-free chick or rat chon- 
drocytes (Fig. 4,  g  and h).  No endogenous matrix was de- 
tected in control cultures at this time point, or by 2  h  (Fig. 
4,  a  and b).  The presence of HA6 prevented the assembly 
of hyaluronan and aggrecan into a  pericellular matrix;  no 
matrix was observed after 2 h (Fig. 4, i and  j), 4 or 48 h (data 
not shown). 
Proteoglycan monomer incorporation into a  hyaluronan- 
anchored pericellular matrix was further studied by adding 
3H-aggrecan to  monolayer cultures of chondrocytes either 
immediately  following  matrix  removal  by  Streptomyces 
Table L Morphometric Analysis of  Matrix Recovery 
Following ~Vash out" of HA6 
0*  4,  24w 
Chick chondrocytes 
+  HA~  1.07  +  .01  1.33  +  .20  1.89  +  .24 
Medium alone  2.07  +  .23  2.30  +  .27  2.91  +  .37 
Rat chondrocytes 
+HA~  1.22  +  .04  1.75  +  .13  2.52  +  .24 
Medium alone  3.00  +  .20  4.13  +  .51  4.54  +  .62 
* (0 h) Represents matrix assembly  in the presence  or absence of HA6 (200 
/~g/ml) for 24 h. 
* (4 h) Represents  matrix  assembly  in fresh  medium  for 4 h following  24 h cul- 
ture in the presence  or absence  of HA~. 
w  (24 h) Represents  matrix assembly  in fresh medium for 24 h following  24 h 
culture in the presence  or absence  of HA~. 
Table I1. Chondrocyte Pericellular Matrix Assembly in the 
Presence of Glycosaminoglycans and Oligosaccharides 
Condition  Chick chondrocytes  Rat chondrocytes 
Medium alone  2.65  +  0.41  3.29  +  0.29 
Hyaluronan  2.97  +  0.21  3.29  +  0.20 
HA~ (0.05  mg/ml)  1.70  +  0.15  2.08  +  0.11 
HA~ (0.1  mg/ml)  1.67  +  0.20  1.47  +  0.08 
HA~ (0.15  mg/ml)  1.27  +  0.18  1.30  +  0.10 
HA~ (0.2 mg/ml)  1.09  +  0.03  1.16  +  0.06 
HA6 (0.25  mg/ml)  1.07  +  0.01  1.22  5:0.05 
Chondroitin sulfate  2.74  +  0.39  2.69  +  0.19 
ChSO4 hexasacchaddes  2.46  +  0.23  2.44  +  0.18 
Matrix-free  chondrocytes  were incubated for 24 h in medium containing  the 
glycosaminoglycan  listed under condition. 
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3 h  5h  18h  24h 
Chick chondrocytes 
+  Hyaluronan  1.46  +  .12  1.58 •  .17  2.33  5:.28  2.93  5:.42 
Medium alone  1.50  +  .15  1.77  +  .27  2.40 +  .34  2.63  +  .42 
Rat chondrocytes 
+  Hyaluronan  1.23  +  .04  1.46  +  .10  2.57  +  .26  3.15  +  .22 
Medium alone  1.38  +  .12  1.67  +  .20  2.48  +  .26  3.00  +  .31 
Matrix-free chondrocytes  were incubated in medium with or without hyaluronan  and matrix assembly monitored at 3, 5, 18, and 24 h. 
Figure 2. Matrix displacement by exogenous hyalumnate hexasaccharides.  Chondrocytes in monolayer culture for 20 h, exhibit a periceUular 
matrix (a, chick; c, rat).  These chondrocytes were incubated  for 2 h more in medium containing HA6 which resulted  in matrix displace- 
ment (b, chick; d, rat).  Bar,  50 ~tm. 
hyaluronidase,  or after 24 h  of matrix regrowth.  Aggrecan 
did not bind to the monolayers of matrix-free chondrocytes, 
but  exogenous  aggrecan  did  become  associated  with  the 
monolayers of chondrocytes with fully assembled pericellu- 
lar matrices  (Table V). 
Specificity of  HA6 D!splacement of  Matrix 
Exogenous pericellular matrices were established on matrix- 
free  chondrocytes  using  exogenous  link-stabilized  aggre- 
can/hyaluronan aggregates. The cells assembled a pericellu- 
lar  matrix  with  the exogenous components within  90 min 
Table IV. Displacement of  Endogenous Matrix 
Condition  Chick chondrocytes  Rat chondrocytes 
2 h cultures 
Medium alone  2.58  +  0.22  2.31  +  0.20 
Hyaluronan  2.59  +  0.36  2.32  +  0.41 
HA~  1.04  +  0.03  1.04  +  0.03 
Chondroitin  sulfate  2.72  +  0.43  2.44 •  0.30 
ChSO4 hexasaccharides  2.23  +  0.23  2.12  •  0.21 
Aggrecan  3.63  +  0.33  3.09  +  0.32 
20 h cultures 
Medium alone  3.08  +  0.31  3.24 •  0.74 
HA~  1.03  +  0.03  1.09  +  0.08 
Chondroitin  sulfate  3.30 +  0.39  3.31  5:0.31 
ChSO4 hexasaccharides  3.08  +  0.45  3.18  •  0.35 
Matrix-free chondroeytes  were grown in monolayer  culture for 2 or 20 h. At 
these time points, the medium was removed and replaced with medium alone 
or medium containing hyaluronan, HA6, chondroitin  sulfate, chondroitin  sul- 
fate (ChSO4), hexasaecharides, or rat chondrosarcoma  proteoglycan mono- 
mer, and all cultures were incubated for an additional 2 h. 
(matrix/cell ratio  =  2.5  +  0.2).  When chondrocytes with a 
reassembled  link-stabilized  periceUular  matrix  (90  min) 
were  subsequently  incubated  with  fresh  media containing 
HA~  for  2  h,  the  periceUular  matrix  was  displaced  (ma- 
trix/cell ratio  =  1.12  +  0.15).  Since link protein-stabilized 
aggrecan/hyaluronan  aggregates  cannot  be  disrupted  by 
hyaluronan  or  hyaluronan  oligosaccharides  (Hascall  and 
Heinegard, 1974), these results support that matrix displace- 
ment  occurred  via  competition  of  HA6  for  hyaluronan/ 
hyaluronan receptor binding. 
Domain Structure of  Aggrecan Required for 
PericeUular Matrix Assembly 
Aggrecan from bovine nasal and bovine articular  cartilage 
were compared and found to support matrix assembly with 
hyaluronan on rat chondrocytes as effectively as rat ehon- 
drosarcoma aggrecan (matrix/cell ratios =  3.06 +  0.30; 3.40 
+  0.21, respectively). Modified rat chondrosarcoma aggre- 
can was added to matrix-free chondrocytes to determine the 
domain structure of aggrecan required for matrix assembly; 
the following results are shown in Table VI. If hyaluronan 
and reduced/alkylated  aggrecan were added,  no matrix as- 
sembled; this suggests that matrix assembly is mediated via 
the interaction of  the hyaluronic acid binding region of aggre- 
can with hyaluronan. However, if either the hyaluronic acid 
binding  region or the  chondroitin  sulfate-rich  region,  ob- 
tained  by  clostripain  digestion  of  aggrecan  followed  by 
cesium chloride gradient centrifugation,  were added in the 
presence of hyaluronan, no matrix assembled. If hyaluronan 
and  chondroitinase  ABC  pre-treated  aggrecan  monomer 
(which stills aggregates with hyaluronan, but has only stubs 
of chondroitin sulfate)  were added,  no matrix  assembled. 
Knudson l-lyaluronan Receptor in Chondrocyte Matrix Assembly  829 Figure 3. Chondrocytes in suspension  culture; matrix assembly and displacement.  Chondrocytes were grown in suspension  for 48 h over 
0.06% polyhema coating, transferred  to six-well plates and spun at 500 g for 15 min; the particle exclusion assay revealed the pericellular 
matrix.  (a) Matrix formed on chick chondrocytes in suspension.  (b) Chick chondrocytes cultured in suspension  for 48 h to which HA6 
were added for 3 h more; the matrix was displaced.  (c) Matrix formed on rat chondrocytes in suspension.  (d) Rat chondrocytes cultured 
in suspension  for 48 h to which HA6 were added for 3 h more; the matrix was displaced.  Bar,  50 #m. 
Figure  4.  Matrix  assembly 
with  exogenous  macromole- 
cules. Streptomyces hyaluroni- 
dase-treated  chick (a, c, e, g, 
and i) and rat (b, d,f, h, and  J3 
chondrocytes were incubated 
with either:  medium alone for 
2  h  (a and b);  medium con- 
taining hyaluronan  for 2 h (c 
and  d);  medium  containing 
aggrecan  for 2  h  (e  and jr); 
medium  containing  hyaluro- 
nan plus aggrecan for 30 min 
(g and h); or medium contain- 
ing hyaluronan  plus aggrecan 
plus  HA6 for 2  h  (i  and j). 
Only  cells  incubated  in  the 
presence  of both  hyaluronan 
and  aggrecan  exhibited  sig- 
nificant pericellular matrices (g 
and  h)  and  the  inclusion  of 
HA~ inhibited  matrix  forma- 
tion  with  these  macromole- 
cules  (i and j).  Bar,  50 #m. 
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Time following S.  hyaluronidase treatment  cpm bound per  10  s cells 
Chick chondrocytes  Rat chondrocytes 
(h) 
0  220 +  32  415 +  7 
24  5,400 +  215  6,780 + 485 
Monolayer chondrocyte cultures were pre-treated with Streptomyces hyaluronidase, and incubated in serum-free medium containing ~H-aggrecan  (O h), or al- 
lowed to regrow a matrix for 24 h  in complete medium, and then incubated with 3H-aggrecan  (24 h). 
PericeUular Matrix Assembly on 
Glutaraldehyde-fixed  Chondrocytes 
To exclude the possibility that exogenous matrix components 
stimulated  endogenous  matrix  synthesis  and  assembly, 
studies  were  performed  on  fixed,  non-living  cells.  It  is 
known from previous studies that hyaluronan receptors are 
stable to  mild fixation with glutaraldehyde and  still bind 
3H-hyaluronan with  specificity and affinity comparable to 
live cells (Nemec et al.,  1987). After incubation of matrix- 
free glutaraldehyde-fixed  chondrocytes in serum-free medium 
containing hyaluronan and aggrecan, a pericellular matrix 
assembled (Fig. 5, a  and b). Pericellular matrices on fixed 
chondrocytes did not form without the addition of the exoge- 
nous hyaluronan and aggrecan. Addition of equivalent con- 
centrations  of hyaluronan  without  aggrecan  or,  aggrecan 
without hyaluronan to the fixed chondrocytes did not result 
in pericellular matrix assembly. Addition of excess HA6 in- 
hibited  matrix  assembly  in  the  presence  of  exogenous 
hyaluronan and aggrecan. 
The persistence or stability of these exogenous pericellu- 
lar  matrices  on fixed chondrocytes was  determined.  The 
cells were rinsed to remove the hyaluronan and aggrecan still 
in solution and not bound to the cells, and fresh medium with 
or  without  HA6 added.  After 24 h,  these fixed chondro- 
cytes in medium alone, retained the matrix (Fig. 5, c and d). 
However, if the fresh medium contained HA6,  the matrix 
formed  by  exogenous hyaluronan  and  aggrecan  on  fixed 
chondrocytes was displaced (Fig. 5, e and f). Also, the ma- 
trix formed by exogenous hyaluronan and aggrecan on fixed 
chondrocytes was removed by treatment with Streptomyces 
hyaluronidase (matrix/cell ratio  =  1.03 +  0.02). 
To insure the absence of  the hyaluronan receptor, chondro- 
cytes were treated with 0.25%  trypsin for 60 min, rinsed, 
and fixed with glutaraldehyde.  No binding of 3H-hyaluro- 
nan to ceils is detected following trypsin treatment (Knudson 
and Toole, 1987;  Nemec et al.,  1987). After incubation of 
trypsin-pretreated,  fixed chondrocytes in  suspension  with 
optimal  concentrations  of  hyaluronan  and  aggrecan,  no 
pericellular matrix assembled (matrix/cell ratio  =  i.i0  + 
0.04),  whereas matrix assembly did occur on fixed, non- 
trypsin treated chondrocytes (Fig.  5, a  and b). 
Table VI. Requirement  for Intact 
Aggrecan Plus Hyaluronan for Matrix Assembly 
with Exogenous Macromolecules 
Condition  Chick chondrocytes  Rat chondrocytes 
+  HA  1.02  +  0.02  1.01  +  0,02 
+  PG  1.01  +  0.02  1.21  +  0.05 
+  HA  +  PG  2.39  -t- 0.33  2.74  +  0.26 
+  HA  +  PG  +  HA6  1.07  +  0.03  1.07  :t:  0.04 
+  HA  +  HABR  1.03  +  0.03  1.02  +  0.02 
+  HA  +  CS-R  1.04  +  0.03  1.05  +  0.03 
+  HA  +  R/A-PG  1.04  +  0.02  1.05  +  0.03 
+  HA  +  C'ase-PG  1.06  +  0.04  1.03  +  0.03 
Matrix-free chondrocytes were incubated for one hour with medium plus the 
components indicated.  PG, aggrecan from rat chondrosarcoma tumor; HABR, 
hyaluronic acid binding region of aggrecan; CS-R, the cbondroitin sulfate-rich 
region of aggrecan (minus the hyaluronic acid binding region); R/A-PG, aggre- 
can following reduction alkylation to inactivate the hyaluronan bindng activity; 
C'ase-PG, aggrecan following chondroitinase ABC removal of chondroitin sul- 
fate chains. 
Figure 5. Assembly of a pericellular matrix with exogenous macro- 
molecules on matrix-free, glutaraldehyde-fixed  chondrocytes. Chick 
(a, c, and e) and rat (b, d, and  f) chondrocytes, which were trypan- 
blue inclusive, were incubated in DME containing hyaluronan and 
aggrecan; matrix assembly was observed at 24 h (a and b). This 
medium was removed and replaced with new DME for 24 h or 
DME containing HA~ for 3 h. Cells in DME alone, representing 
non-specific shedding into the culture medium, retained the matrix 
(c and at). Incubation of cells in DME containing HA6 resulted in 
the displacement of the pericellular matrix from the fixed chondro- 
cytes (e and f). Bar, 50/~m. 
Knudson Hyaluronan Receptor in Chondrocyte Matrix Assembly  831 Table VII. Capacity  of  Proteoglycan Recovered  from the 
Medium to Aggregate with Hyaluronan 
Time  HA~  Chick chondrocytes  Rat chondrocytes 
(h)  (%)  (%) 
24 h  +  34  24 
24 h  -  13  14 
48 h  +  45  71 
48 h  -  44  70 
Values represent the percentage of macromolecular 35S-labeled material elut- 
ing at the Vo of Sepharose CL-2B; that is the capacity of ~SS-proteoglycan to 
form stable aggregates with exogenous hyaluronan. Labeled media from chon- 
drocytes cultured in the presence or absence of HA~ for 24 or 48 h  were 
analyzed, 
Aggregation Competence of  Newly 
Synthesized Proteoglycans 
To test whether  aggrecan  synthesized  in  the presence of 
HAs has  the same capacity to aggregate  with hyaluronan, 
35S-proteoglycans obtained from the medium of chondro- 
cytes cultured in the presence or absence of HAs were com- 
pared. The capacity of the 3sS-proteoglycan to form stable 
aggregates with hyaluronan  was determined as the percent- 
age of proteoglycan eluting at the Vo of a Sepharose CL-2B 
column after aggregation with 6 % exogenous hyaluronan for 
24 h. In the presence of HAs the percentage of aggregating 
proteoglycans  at 24 h was slightly  increased for both cell 
types; however, equivalent  percentage of aggregating  pro- 
teoglycans  were found in the medium at 48 h (Table VII). 
Discussion 
Although many matrix macromolecules within cartilage are 
capable  of cell-free  self-assembly,  the  hypothesis  of this 
study is that initial assembly occurs within a zone immedi- 
ately adjacent to the chondrocyte cell surface termed the 
cell-associated or pericellular matrix. The three components 
of the matrix aggregate  in cartilage-hyaluronan,  aggrecan 
and link protein-are synthesized  by the chondrocytes.  Of 
these three, only aggrecan and link protein pass through the 
RER and Golgi compartments,  where cytoplasmic interac- 
tions could occur (Hardingharn  et al.,  1992).  The current 
model for hyaluronan biosynthesis is of a plasma membrane 
enzyme complex, by which newly elongating hyaluronan  is 
extruded to the extracellular  matrix (Prehm,  1989; Ng and 
Schwartz,  1989).  Thus aggrecan  and link protein can only 
interact with hyaluronan extracellularly.  Previous studies in- 
dicated  specific  interaction  between the  hyaluronan  acid 
binding  region of aggrecan  and hyaluronan  at the chondro- 
cyte cell  surface  (Sommarin  and  Heinegard,  1983),  but 
aggrecan  receptors have  not been detected.  Also,  newly 
secreted aggrecan  is converted, in the extracellular  matrix, 
to a form with a higher finding affinity for hyaluronan (Sandy 
and Plaas,  1989; Sandy et al., 1989). The control or cataly- 
sis  of cartilage  matrix  assembly  may  therefore  require 
specific cell-matrix interactions,  which are in turn,  medi- 
ated via membrane binding proteins or receptors. The inter- 
actions of matrix macromolecules with cell surface receptors 
would allow macromolecules to be clustered in proportions 
and concentrations  which assure optimal  assembly in the 
pericellular compartment.  The pericellular matrix, once as- 
sembled, may then serve as a nucleating  template for ter- 
ritorial or interterritorial  matrix organization. 
Extensive  pericellular matrices,  of varying  thicknesses, 
have been visualized surrounding  a wide variety of eukary- 
otic cells in culture (Laurent and Fraser,  1992). The prin- 
cipal feature known concerning the structural composition of 
these pericellular  matrices  is  that  they are dependent on 
hyaluronan.  In previous studies,  however, we observed that 
cells of embryonic limb mesenchyme could turn on, or off, 
the expression of pericellular matrices without change in the 
levels of their cell surface hyaluronan,  suggesting that other 
components are required for matrix formation (Knudson and 
Toole,  1985).  The removal of the chondrocyte pericellular 
matrix  by treatment  with a dilute solution  of Streptomyces 
hyaluronidase,  led  to  the  hypothesis  that  a  network  of 
hyaluronan  is the scaffold for the chondrocyte pericellular 
matrix,  to which other matrix macromolecules are bound 
(Knudson and Toole, 1985, 1987). The in vivo presence or 
function  of extensive pericellular matrices which surround 
many cell types in culture is not well established.  Clearly, 
the expression of pericellular matrices around chondrocytes 
correlates  well  with  their  primary  cellular  function;  to 
generate  and  organize  an  extraceUular  matrix  capable of 
withstanding  load forces.  The interactions  of chondrocytes 
with the extracellular  matrix may provide a mechanism  for 
the cells to respond to the composition and/or mechanical 
properties of this  surrounding  matrix.  The degree of ex- 
tracellular  matrix  surrounding  chondrocytes in  vivo also 
seems to correlate well with the expression of pericellular 
matrices in vitro,  suggesting that these structures do in fact 
exist in vivo (Knudson  and Toole,  1985). 
To determine that these cell-associated matrices visualized 
by  the  particle  exclusion  assay  were  not  an  artifact  of 
monolayer  culture,  we  developed  techniques  to  analyze 
chondrocytes grown in suspension  culture.  Via a modified 
cytospin technique,  cells  in  suspension were centrifuged 
("splatted'3 onto a plastic well assay surface. The cells were 
found to exhibit  pericellular matrices similar  to those ob- 
served on chondrocytes grown on monolayer culture.  Thus, 
cells in suspension also elaborate a pericellular matrix which 
can be visualized in our two-dimensional  assay by the rapid 
splatting  of cells before visualization.  With this method it 
was now possible to determine whether chondrocytes elab- 
orate such a matrix  in vivo. In a preliminary study (Knud- 
son, C. B. 1991. J. Cell Biol. 115:297), chondrocytes were 
isolated from the 12-d embryonic chick tibiae by a  10-min 
treatment of the cartilage with purified collagenase P (Boeh- 
ringer Mannheim  Biochemicals,  Indianapolis,  IN), in me- 
dium containing  20% FBS. The freshly isolated single cells 
were diluted,  splatted onto the six-well plastic  culture sur- 
face and visualized by the particle exclusion assay. The newly 
isolated chondrocytes exhibited prominent pericellular ma- 
trices (matrix/cell  ratio =  3.21 + 0.20) similar in size to the 
cultured chondrocytes.  This matrix was displaced by sub- 
sequent 3-h incubation  in medium with HAS. 
The first conclusion of this study is that the ability to as- 
semble a pericellular matrix requires the expression  of cell 
surface hyaluronan binding sites or "receptors" and the inter- 
action of hyaluronan  with these receptors. This conclusion 
was drawn because the pericellular matrices could be pre- 
vented from assembling or, displaced from the cells once as- 
sembled, via the addition  of an excess of HAs, competitive 
inhibitors of the binding of hyaluronan to its receptor.  These 
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scaffolding of a hyaluronan network but actually anchored to 
the chondrocyte cell surface via hyaluronan/hyaluronan  re- 
ceptor interactions.  Exogenous hyaluronan  did not inhibit 
matrix assembly or displace intact matrices.  High molecular 
weight hyaluronan  added exogenously does bind to matrix- 
free chondrocytes (Knudson and Toole.,  1987; McCarthy 
and Toole, 1989), and thus may be incorporated into the ma- 
trix, exchanging for endogenous receptor-bound hyaiuronan 
and supporting proteoglycan aggregate formation and reten- 
tion.  However, in the presence of HA6, when potentially  all 
cell surface hyaluronan receptors are occupied with hexasac- 
charides which are too small to mediate proteoglycan aggre- 
gate formation, the assembly and retention of  the pericellular 
matrix is inhibited. Thus receptor-bound hyaluronan appears 
to serve as the periceUular  matrix anchor. 
When added to pre-chondrogenic micromass cultures es- 
tablished from embryonic chick limb bud mesoderm, HA~ 
inhibits  chondrogenesis,  a process believed to be mediated 
via hyaiuronan receptors (Toole, 1991; Maleski, M. P., and 
C. B. Knudson.  1992.  Trans. Orthop. Res. Soc. 17:105). A 
rnAb  (IVd4)  was  generated  by Toole  and  his  colleagues 
(1991), directed against a hyaluronan receptor present in em- 
bryonic chick tissues. Analogous to the HA~, this antibody 
blocks binding  of 3H-hyaluronan  to hyaluronan  receptors 
(Banerjee and Toole, 1991), inhibits assembly of newly syn- 
thesized pericellular matrices on chondrocytes (Yu et al., 
1992)  and  inhibits  chondrogenesis  of micromass cultures 
(Toole,  1991). 
To determine the components minimally required to estab- 
lish a chondrocyte pericellular matrix, namely a matrix that 
can exclude particles, purified exogenous  macromolecules 
were added back to matrix-free chondrocytes.  Only when ex- 
ogenous hyaluronan  was added in combination with intact 
aggrecan  did a pericellular matrix assemble. The presence 
or absence of keratan sulfate on the aggrecan did not affect 
matrix assembly.  These results  suggest that the matrix ob- 
served by the particle exclusion assay depends on the space 
occupied by the chondroitin  sulfate chains of the aggrecan. 
However, the aggrecan  must interact  with hyaluronan  to be 
retained at the chondrocyte cell surface; the hyaiuronan  be- 
ing anchored to the cell surface via the hyaluronan receptor, 
and  displaceable by HA6. The  second conclusion of this 
study is that hyaluronan  and intact aggrecan,  decorating the 
hyaluronan  in aggregate  form, are essential for matrix for- 
mation.  Addition  of exogenous  link-stabilized  hyaluronan/ 
aggrecan  aggregates  also supported matrix  assembly and, 
more importantly,  the link-stabilized  matrix could still be 
displaced by HA6. This also supports the conclusion that 
the displacement of the cell-associated, proteoglycan aggre- 
gate pericellular matrix by HA6 is via competition with hyal- 
uronan/hyaluronan  receptor interactions and not hyaluronan/ 
aggrecan interactions.  This later interaction  occurs between 
aggrecan  and hyaluronan  oligosaccharides of a decasaccha- 
ride  size  or larger,  with  specific  structural  requirements 
(Hascail and Heinegard,  1974; Christner et ai.,  1977). 
To determine whether the addition  of exogenously added 
macromolecules promoted matrix assembly by stimulation 
of endogenous matrix production,  nonliving  chondrocytes 
mildly fixed by treatment with 1% glutaraidehyde  were as- 
sayed. Addition  of hyaluronan  and aggrecan  to fixed chon- 
drocytes in the absence of serum resulted in periceUular ma- 
trix  assembly  comparable  to  live  chondrocytes.  These 
matrices were stable for 24 h without continuous exposure 
to the soluble macromolecules. Therefore the third  conclu- 
sion  from  our current  results  is that  the  formation of a 
pericellular matrix on chondrocytes can be obtained with as 
few as two components,  the addition  of exogenous hyaluro- 
nan and an aggregating  type proteoglycan and that serum 
components are not required. No matrix formed if trypsin 
pre-treated cells were used demonstrating  that matrix assem- 
bly is mediated via a cell surface-associated protein(s). 
In previous studies, to substantiate  the role of the hyaluro- 
nan receptor in matrix assembly exogenous hyaluronan  and 
aggrecan were added to other cultured cell types (Knudson 
and Knudson, 1991). The cell types chosen were ones which 
never exhibit pericellular matrices in culture,  synthesize lit- 
tle hyaluronan  or proteoglycan, yet do express hyaluronan 
receptors similar to those expressed on chondrocytes.  Addi- 
tion of hyaluronan  plus aggrecan  to two different  human 
bladder carcinoma cell lines or to SV-40--transferred  3T3 
cells,  resulted  in the assembly of chondrocyte-like  pericel- 
lular  matrices.  As with the chondrocytes, hyaluronan,  or 
aggrecan  alone were unable to support matrix  assembly; 
HA~ inhibited  matrix assembly or displaced matrices  once 
assembled; and glutaraldehyde-fixed  tumor cells stiU sup- 
ported matrix assembly. Addition of hyaluronan  and aggre- 
can to matrix-deficient  tumor cells which did not express 
hyaluronan  receptors (B16 melanoma and RT-4 papilloma) 
were unable to assemble pericellular matrices.  In addition, 
conditioned  medium  from  rat  fibrosarcoma  cells  (cells 
which exhibit  pericellular matrices) also supported matrix 
assembly, suggesting that other hyaluronan-aggregating  pro- 
teoglycans  (e.g., versican, hyaiuronectin;  see Toole,  1991) 
may also support matrix assembly. 
The influence of hyaluronan  on cell physiology probably 
depends on its hydrodynamic  properties and its interaction 
with the cell surface (Laurent and Fraser, 1992). Inhibition 
of chondrocyte proteoglycan biosynthesis in response to ex- 
ogenous hyaluronan  has been reported for several cell cul- 
ture systems (Wiebkin and Muir,  1973; Solursh et ai., 1974, 
1980; Handley and Lowther,  1976; Bansal et al.,  1986) al- 
though the results  have reflected  undetermined  variability 
(reviewed in Mason et al., 1989). In our studies, exogenous 
hyaiuronan did not inhibit matrix assembly or displace intact 
matrices.  Also, total incorporation  into 3~S-proteoglycans 
was not altered significantly  in the presence of HA6. In the 
presence of HA~, there was an increased accumulation  of 
newly synthesized  proteoglycan in  the medium compart- 
ment,  which was competent to aggregate  with hyaluronan. 
This suggests that a decrease in the synthesis of aggregating 
proteoglycans was not responsible for the blocked matrix as- 
sembly in the presence of HA6, but rather than the reten- 
tion  of  aggrecan  by  receptor-bound  hyaluronan  in  the 
pericellular  matrix  was  blocked in  the presence of HA6. 
These were 24-h experiments,  and the long-term influence 
of matrix displacement via HAs on the chondrocyte pheno- 
type is currently under study. Additionally, through the inter- 
action of these matrix receptors with extracellular  compo- 
nents,  chondrocytes may fine tune their patterns of matrix 
biosynthesis and/or turnover,  as has been previously sug- 
gested by several  investigators  (Wiebkin  and Muir,  1973; 
Solursh et al.,  1974,  1980;  Handley and Lowther,  1976; 
Bansal  et al.,  1986; Morales and Hascail,  1988). 
Matrix assembly and retention at cell surfaces is important 
for the health of any tissue, cartilage in particular.  Chondro- 
Knudson Hyaluronan Receptor in Chondrocyte Matrix Assembly  833 cyte interactions with extracellular matrices are important in 
the maintenance of tissue integrity, and for matrix assembly 
in repair and morphogenesis. These interactions  are medi- 
ated via binding proteins/receptors  for extracellular  matrix 
molecules. Little is known about the distribution of integrins 
on chondrocytes.  Anchorin CII is the major site to anchor 
chondrocytes in their collagen extracellular matrix (Mollen- 
hauer et al., 1984). In their studies, reassembly  of the chon- 
drocyte pericellular matrix was correlated with the intensity 
of  anchorin  CII  immtmoreactivity  on  the  cell  surface 
(Mollenhauer  et al., 1984). Receptors with anchoring func- 
tions may also transduce information from the extracellular 
matrix  influencing  cell  proliferation,  differentiation,  and 
physiology.  The relationship between the interactions of the 
collagens and the proteoglycan aggregates with the chondro- 
cyte surface is under investigation to further our understand- 
ing of the mechanisms used by chondrocytes to interact with 
the extracellular  environment  in healthy and diseased car- 
tilage. 
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